pentoxifylline has been researched along with Diathesis in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with SAH given prednisolone are at greater risk for developing serious infections and infections after treatment than patients not given prednisolone, which may offset its therapeutic benefit." | 9.24 | In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA. ( Allison, M; Atkinson, SR; Austin, A; Forrest, EH; Gleeson, D; Knapp, S; Masson, S; Maurice, J; McCune, A; Patch, D; Richardson, P; Ryder, SD; Thursz, MR; Vergis, N; Wright, M, 2017) |
| "Patients with SAH given prednisolone are at greater risk for developing serious infections and infections after treatment than patients not given prednisolone, which may offset its therapeutic benefit." | 5.24 | In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA. ( Allison, M; Atkinson, SR; Austin, A; Forrest, EH; Gleeson, D; Knapp, S; Masson, S; Maurice, J; McCune, A; Patch, D; Richardson, P; Ryder, SD; Thursz, MR; Vergis, N; Wright, M, 2017) |
| "Pentoxifylline was added after incubation of normal cells with patient serum, and the directed chemotaxis was restored." | 1.28 | Pentoxifylline in vitro reverses neutrophil chemotactic deficiency induced by interleukin-2 treatment. ( Fossat, C; Juhan-Vague, I; Maraninchi, D; Sainty, D; Stoppa, AM, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vergis, N | 1 |
| Atkinson, SR | 1 |
| Knapp, S | 1 |
| Maurice, J | 1 |
| Allison, M | 1 |
| Austin, A | 1 |
| Forrest, EH | 1 |
| Masson, S | 1 |
| McCune, A | 1 |
| Patch, D | 1 |
| Richardson, P | 1 |
| Gleeson, D | 1 |
| Ryder, SD | 1 |
| Wright, M | 1 |
| Thursz, MR | 1 |
| Barluzzi, R | 1 |
| Mazzolla, R | 1 |
| Brozzetti, A | 1 |
| Puliti, M | 1 |
| Mariucci, G | 1 |
| Mosci, P | 1 |
| Bistoni, F | 1 |
| Blasi, E | 1 |
| Fossat, C | 1 |
| Sainty, D | 1 |
| Stoppa, AM | 1 |
| Maraninchi, D | 1 |
| Juhan-Vague, I | 1 |
1 trial available for pentoxifylline and Diathesis
| Article | Year |
|---|---|
In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of Bacterial DNA.
Topics: Adult; Anti-Bacterial Agents; Disease Susceptibility; DNA, Bacterial; Double-Blind Method; Female; F | 2017 |
2 other studies available for pentoxifylline and Diathesis
| Article | Year |
|---|---|
A low virulent strain of Candida albicans enhances brain anticryptococcal defenses: characterization of the local immune reaction by RT-PCR and histochemical analysis.
Topics: Animals; Antibodies, Fungal; Antibody Formation; Brain; Candida albicans; Cryptococcus neoformans; C | 1997 |
Pentoxifylline in vitro reverses neutrophil chemotactic deficiency induced by interleukin-2 treatment.
Topics: Bacteremia; Bone Marrow Transplantation; Cells, Cultured; Chemotaxis, Leukocyte; Disease Susceptibil | 1992 |